These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15817337)

  • 1. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy.
    Fay M; Tan A; Fisher R; Mac Manus M; Wirth A; Ball D
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1355-63. PubMed ID: 15817337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
    Koh ES; Sun A; Tran TH; Tsang R; Pintilie M; Hodgson DC; Wells W; Heaton R; Gospodarowicz MK
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):223-8. PubMed ID: 16904523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters.
    Hope AJ; Lindsay PE; El Naqa I; Alaly JR; Vicic M; Bradley JD; Deasy JO
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):112-24. PubMed ID: 16618575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation.
    Tsujino K; Hirota S; Kotani Y; Kado T; Yoden E; Fujii O; Soejima T; Adachi S; Takada Y
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1100-5. PubMed ID: 16373082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].
    Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis.
    Chang DT; Olivier KR; Morris CG; Liu C; Dempsey JF; Benda RK; Palta JR
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):125-31. PubMed ID: 16427214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of dose-volume histogram parameters for radiation pneumonitis after definitive concurrent chemoradiotherapy for esophageal cancer.
    Asakura H; Hashimoto T; Zenda S; Harada H; Hirakawa K; Mizumoto M; Furutani K; Hironaka S; Fuji H; Murayama S; Boku N; Nishimura T
    Radiother Oncol; 2010 May; 95(2):240-4. PubMed ID: 20223539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates.
    Schallenkamp JM; Miller RC; Brinkmann DH; Foote T; Garces YI
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):410-6. PubMed ID: 17236964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
    Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
    Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY
    Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated assessment of the six-minute walk test as predictor of acute radiation-induced pneumonitis.
    Mao J; Zhang J; Zhou S; Das S; Hollis DR; Folz RJ; Wong TZ; Marks LB
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):759-67. PubMed ID: 17293233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional volumetric analysis of irradiated lung with adjuvant breast irradiation.
    Teh AY; Park EJ; Shen L; Chung HT
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1309-15. PubMed ID: 19427749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of whether radiation pneumonitis is influenced by low-dose irradiated lung volume in primary lung cancer with chronic pulmonary disease.
    Niibe Y; Hayakawa K; Masuda N; Yoshimura H
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):213-6. PubMed ID: 17301529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy.
    Borst GR; Ishikawa M; Nijkamp J; Hauptmann M; Shirato H; Onimaru R; van den Heuvel MM; Belderbos J; Lebesque JV; Sonke JJ
    Radiother Oncol; 2009 Jun; 91(3):307-13. PubMed ID: 19321217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?
    Taghian AG; Assaad SI; Niemierko A; Floyd SR; Powell SN
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):386-91. PubMed ID: 15890579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
    Yorke ED; Jackson A; Rosenzweig KE; Braban L; Leibel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):672-82. PubMed ID: 15939548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.